T3D Therapeutics
Mr. Golden is the founder of John A. Golden Associates, a New York City-based financial advisory firm and investor in private and public companies. He is a retired general partner of Goldman Sachs & Co, the investment banking firm, where he was a leader in its mergers and acquisition advisory business for two decades. He was Board Member and Investor in Seniorbridge Companies, which was acquired in 2012 by Humana. Mr. Golden graduated in 1966 from Colgate University and holds a J.D. from Columbia Law School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
T3D Therapeutics
T3D Therapeutics’ mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease with the potential to slow, stop or reverse the course of the disease.